222. 一次性ネフローゼ症候群 [臨床試験数:234,薬物数:241(DrugBank:78),標的遺伝子数:59,標的パスウェイ数:185

Searched query = "Primary nephrotic syndrome", "Minimal change nephrotic syndrome", "MCNS", "Membranous nephropathy", "Focal segmental glomerulosclerosis", "FSGS", "Membranoproliferative glomerulonephritis", "MPGN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR-IPR-170117022017-07-012017-06-19Compare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroidCompare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroid membranous nephropathymizoribine group:treated with mizoribine and steroid;cyclophosphamide group:treated with cyclophosphamide and steroid;Tianjin First Central HospitalNULLPending1865Bothmizoribine group:50;cyclophosphamide group:50;China
2JPRN-UMIN0000089192012/09/1514/09/2012The prospective multi-center study on the efficacy and safety of mizoribine for the treatment of aged nephrotic patients with primary membranous nephropathy. The patients with nephrotic syndrome due to primary membranous nephropathy.Treatment with a combination of mizoribine plus steroid therapy
Treatment with steroid monotherapy
The study group of treatment for aged patients with nephrotic syndrome.NULLComplete: follow-up complete65years-oldNot applicableMale and Female200Not appl1cableJapan
3JPRN-C0000001582006/03/0101/04/2006Mizoribin for primary nephrotic syndrome in children(JSRDC09) Steroid-sensitive nephrotic syndromemizoribine+prednisoloneJapanese Study Group of Renal Disease in Children(JSRDC)NULLComplete: follow-up complete1years-old10years-oldMale and Female50Not selectedJapan
4JPRN-C0000003682004/04/0127/03/2006Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome membranous nephropathy with primary steroid resistant nephrotic syndromemizoribine once a day per os administration (150mg) after breakfast for 2years.



mizoribine 3 times a day per os administration (50mg each) after meals for 2years.
Project team for treatment of refractory nephrotic syndromeThe Progressive Renal Disease Research Projects in the Ministry of Health, Labor and Welfare, JapanComplete: follow-up complete16years-old75years-oldMale and Female100Not selectedJapan
5JPRN-C0000003792001/04/0101/04/2006Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06) Steroid-sensitive nephrotic syndromeprednisolone
mizoribine+prednisolone
Japanese Study Group of Renal Disease in Children(JSRDC)NULLComplete: follow-up complete1years-old10years-oldMale and Female50Not selectedJapan